December 14, 2016 By Danielle Kirsh Three new studies demonstrate value of MammaPrint and BluePrint in individualizing treatment for breast cancer patients
December 2, 2016 By Abigail Esposito Agendia’s MammaPrint and BluePrint tests highlighted in multiple presentations at the 2016 San Antonio Breast Cancer Symposium
June 8, 2016 By Abigail Esposito Agendia’s MammaPrint can prevent under and over treatment of breast cancer patients